Celsius Holdings, Inc. (Nasdaq: CELH), makers of the leading fitness drink, CELSIUS®, today announced that John Fieldly, interim Chief Executive Officer, President and Chief Financial Officer,...

Amplyx Pharmaceuticals, a biotechnology company developing novel antimicrobial agents for life-threatening fungal infections, today announced that seven posters from the APX001 development program...

3 Daughters Brewing, one of the fastest-growing regional breweries from Florida, has been awarded the 2017 Emerging Business Achievement Award during the U.S. Chamber of Commerce's annual Dream...

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced that Norbert G. Riedel, Ph.D., President and CEO,...

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from three studies featuring its Decipher® Prostate and Bladder Cancer...